| Target-based selection of flavonoids for neurodegenerative disorders QRD Jones, J Warford, HPV Rupasinghe, GS Robertson Trends in pharmacological sciences 33 (11), 602-610, 2012 | 123 | 2012 |
| Neuroprotective and anti-inflammatory effects of the flavonoid-enriched fraction AF4 in a mouse model of hypoxic-ischemic brain injury PGW Keddy, K Dunlop, J Warford, ML Samson, QRD Jones, ... PLoS One 7 (12), e51324, 2012 | 53 | 2012 |
| Global ablation of the mitochondrial calcium uniporter increases glycolysis in cortical neurons subjected to energetic stressors M Nichols, PA Elustondo, J Warford, A Thirumaran, EV Pavlov, ... Journal of Cerebral Blood Flow & Metabolism 37 (8), 3027-3041, 2017 | 44 | 2017 |
| Human brain chemokine and cytokine expression in sepsis: a report of three cases J Warford, AC Lamport, B Kennedy, AS Easton Canadian Journal of Neurological Sciences 44 (1), 96-104, 2017 | 36 | 2017 |
| Surfen, a proteoglycan binding agent, reduces inflammation but inhibits remyelination in murine models of Multiple Sclerosis JR Warford, AC Lamport, DR Clements, A Malone, BE Kennedy, Y Kim, ... Acta neuropathologica communications 6, 1-21, 2018 | 28 | 2018 |
| The flavonoid-enriched fraction AF4 suppresses neuroinflammation and promotes restorative gene expression in a mouse model of experimental autoimmune encephalomyelitis J Warford, QRD Jones, M Nichols, V Sullivan, HPV Rupasinghe, ... Journal of neuroimmunology 268 (1-2), 71-83, 2014 | 23 | 2014 |
| The cytokine and endocannabinoid systems are co-regulated by NF-κB p65/RelA in cell culture and transgenic mouse models of Huntington's disease and in striatal tissue from … RB Laprairie, JR Warford, S Hutchings, GS Robertson, MEM Kelly, ... Journal of neuroimmunology 267 (1-2), 61-72, 2014 | 18 | 2014 |
| Murine experimental autoimmune encephalomyelitis is diminished by treatment with the angiogenesis inhibitors B20-4.1. 1 and angiostatin (K1-3) CJ MacMillan, CD Doucette, J Warford, SJ Furlong, DW Hoskin, ... PLoS One 9 (2), e89770, 2014 | 14 | 2014 |
| Orthogonal analysis of dystrophin protein and mRNA as a surrogate outcome for drug development K Uaesoontrachoon, S Srinivassane, J Warford, K Mekhssian, H Montpetit, ... Biomarkers in Medicine 13 (14), 1209-1225, 2019 | 10 | 2019 |
| Murine T cell activation is regulated by surfen (bis-2-methyl-4-amino-quinolyl-6-carbamide) J Warford, CD Doucette, DW Hoskin, AS Easton Biochemical and Biophysical Research Communications 443 (2), 524-530, 2014 | 9 | 2014 |
| New methods for multiple sclerosis drug discovery J Warford, GS Robertson Expert Opinion on Drug Discovery 6 (7), 689-699, 2011 | 8 | 2011 |
| The Text4HealthyAging program: an evidence-based text messaging innovation to support healthy urban aging in Canada and Australia E Eboreime, A Ohinmaa, B Rusak, KL Cassidy, J Morrison, P McGrath, ... Gerontology and Geriatric Medicine 8, 23337214221081378, 2022 | 4 | 2022 |
| Augmenting mental health support for patients accessing different degrees of formal psychiatric care through a supportive text messaging program: protocol for a randomized … RL Dias, R Shalaby, B Agyapong, G Obuobi-Donkor, MK Adu, ... Methods and Protocols 6 (1), 19, 2023 | 1 | 2023 |
| Surfen, a proteoglycan antagonist, reduces lysolecithin-induced demyelination with related effects on macrophage function J Warford, L Madera, D Hoskin, A Easton Journal of Neuroimmunology 275 (1), 73, 2014 | 1 | 2014 |
| Reducing wait times and avoiding unnecessary use of high-cost mental health services through a Rapid Access and Stabilization Program: protocol for a program evaluation study MK Adu, R da Luz Dias, G Obuobi-Donkor, N Ezeanozie, S Sridharan, ... BMC Health Services Research 24 (1), 247, 2024 | | 2024 |
| REGISTRIES AND CARE OF NEUROMUSCULAR DISORDERS: P. 297Treatment responsive outcome measures in mouse models of neuromuscular disease A Mullen, K Uaesoontrachoon, S Srinivassane, M Moraca, W Ross, ... Neuromuscular Disorders 28, S120-S121, 2018 | | 2018 |
| THE EFFECTS OF THE PROTEOGLYCAN ANTAGONIST SURFEN ON ANIMAL MODELS OF DEMYELINATION WITH COMPARISON TO IN VITRO T CELL AND MACROPHAGE RESPONSES J Warford | | 2018 |
| Proteoglycans as a double-edged sword in multiple sclerosis: Implications for future approaches to immunomodulatory therapy J Warford, AC Lamport, DW Hoskin, AS Easton Canadian Journal of Neurological Sciences 44 (S1), S6-S6, 2017 | | 2017 |
| Compared to normals, the cerebral expression of multiple inflammatory markers is reduced in Alzheimer’s disease and Diffuse Lewy body disease AC Lamport, J Warford, AS Easton Canadian Journal of Neurological Sciences 42 (S3), S3-S3, 2015 | | 2015 |
| Understanding the role of surfen, a proteoglycan antagonist, in mouse models of multiple sclerosis: Applications for the development of novel therapeutics J Warford, AC Lamport, DW Hoskin, AS Easton Canadian Journal of Neurological Sciences 42 (S3), S3-S4, 2015 | | 2015 |
